CDC42 and early-onset autosomal dominant Alzheimer disease: Furthermore, disruption of Cdc42 function in the nervous system has been implicated in Alzheimer’s disease [68], schizophrenia [69], epilepsy [70,71] and neurofibromatoses [72].